WASHINGTON: The ousted director of a U.S. agency responsible for developing drugs to fight the coronavirus pandemic filed a whistleblower’s complaint on Tuesday accusing President Donald Trump’s administration of retaliating when he raised concerns. Rick Bright says in the complaint
Read More